Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Brief
|
A Datamonitor analyst opinion piece on the current state of the mHealth market.
Published By Datamonitor
|
24 Dec 2009 |
$150
|
Brief
|
Overview of the life sciences industry and key opportunities for technology vendors
Published By Datamonitor
|
12 Mar 2010 |
$1895
|
Brief
|
This brief outlines key business issues and technology enablers that are expected to affect the healthcare industry during 2010.
Published By Datamonitor
|
09 Dec 2009 |
$1895
|
Brief
|
Technology markets are changing fast. This brief is essential reading for you to identify and track the key forces shaping the prospects for your business.
Published By Datamonitor
|
25 Dec 2009 |
$1895
|
Brief
|
This brief outlines key business issues and technology enablers that are expected to affect the pharmaceutical industry during 2010.
Published By Datamonitor
|
09 Dec 2009 |
$1895
|
Report
|
Datamonitor’s report 5EU: Pricing, Reimbursement, and Regulatory Update provides an overview of developments regarding healthcare reforms, drug regulation, and drug pricing and reimbursement in France, Germany, Italy, Spain, and the UK.
Published By Datamonitor
|
28 Oct 2011 |
$1900
|
Report
|
Analysis of Abbott's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017
Published By Datamonitor
|
08 Aug 2012 |
$5700
|
Report
|
The number of approvals for new drugs has fallen steadilyin recent years, despite increasing R&D expenditure. Improvements in lead generation essential for companies aiming to avoid expensive compound failures in the later stages of development.
Published By Business Insights
|
01 Jun 2009 |
$3835
|
Report
|
'Accelerating Lead Generation: Emerging technologies and strategies' provides an in-depth examination of state-of-the-art technologies for lead generation. This report assesses the potential of new and emerging technologies for improving the quality of drug candidates entering clinical research, and reviews the benefits associated with different approaches to lead generation, including high throughput screening, fragment based drug discovery and virtual screening.
Published By Business Insights
|
01 Jun 2009 |
$3835
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.